ArticlePloS one2024

In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.

Muhammad Habibulla Alamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.